Pharmaceutical products and services focused on CNS, Cardio-Diabetic, Critical Care, and General segments.
Annual revenue $750,142 Latest available
Total funding - Funding intelligence
Employees 18 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Snig Pharma

Snig Pharma is a company. The company has 18 employees as of March 29, 2024. Snig Pharma offers products and services including Valnigo and Snigmin.

  • Employees 18 as on 29 Mar, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Snig Pharma Pvt. Ltd
  • Jurisdiction Sahakar Nagar A Block Bengaluru, Karnataka, India
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $750.14 K (USD)
    11.7
    as on Mar 31, 2022
  • Net Profit
    $101.73 K (USD)
    -49.45
    as on Mar 31, 2022
  • EBITDA
    $115.67 K (USD)
    -53.9
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    18

    as on Mar 29, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Snig Pharma

Snig Pharma offers a comprehensive portfolio of products and services, including Valnigo and Snigmin.

Product name locked
Category locked
Primary

Valnigo is utilized for treating ailments in therapeutic segments like CNS.

Product name locked
Category locked
Locked

Snigmin is employed for general health purposes across various therapeutic areas.

Funding Insights of Snig Pharma

Premium access

Detailed funding history for Snig Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Snig Pharma

Investments
Premium access

Investment portfolio details for Snig Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Snig Pharma

Premium access

Detailed financials for Snig Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Snig Pharma Comparisons

Snig Pharma Primary company
Description
Pharmaceutical products and services focused on CNS, Cardio-...
Location
-
Founded Year
-
Annual Revenue
$750.14 K (USD)
Net Profit
$101.73 K (USD)
EBITDA
$115.67 K (USD)
Employees
18
As of 2024
Premium access

Peer comparison for Snig Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Snig Pharma

Premium access

Detailed competitors of Snig Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Snig Pharma

Premium access

Complete news archive for Snig Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Snig Pharma

As of Mar 29, 2024, the latest employee count at Snig Pharma is 18.

Annual revenue of Snig Pharma is $750.14K as on Mar 31, 2022.

Snig Pharma Pvt. Ltd. is identified as a pharmaceutical company that provides a portfolio of products designed to prevent, treat, and cure ailments across therapeutic segments including CNS, Cardio-Diabetic, Critical Care, and General. High-quality and affordable medicines are made accessible to those in need through partnerships with healthcare providers, governments, and non-governmental organizations. A commitment is maintained towards patients, medical professionals, employees, business associates, and shareholders to address ever-increasing health needs, emphasizing quality, reliability, and sustainability in manufacturing processes.

Snig Pharma offers Valnigo and Snigmin.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available